Inactivating mutations of TP53 are more prevalent in CCA with a fluke infection etiology, as are mutations of ARID1A, ARID2, BRCA1 and BRCA2, than in non-fluke related CCAs [34,53–56]. This evidence concerns the gene BRCA2 and cholangiocarcinoma.